Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. - Cunningham,D.; Humblet,Y.; Siena,S.; Khayat,D.; Bleiberg,H.; Santoro,A.; Bets,D.; Mueser,M.; Harstrick,A.; Verslype,C.; Chau,I.; Van Cutsem,E. (N Engl J Med, 2004)